Related Experiment Video
Updated: Jul 31, 2025

A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
Group B Streptococcus in Pregnancy
Jenny Y Mei1, Neil S Silverman1
1Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, 200 Medical Plaza, Suite 430, Los Angeles, CA 90095-1740, USA.
Insights
Preventing early-onset neonatal sepsis from group B streptococcus (GBS) involves screening pregnant patients and administering intrapartum antibiotic prophylaxis (IAP) when indicated. Prompt IAP significantly reduces GBS transmission risks to newborns.
Area of Science:
- Obstetrics and Gynecology
- Neonatal Medicine
- Infectious Disease
Background:
- Group B Streptococcus (GBS) poses a significant risk for early-onset neonatal sepsis.
- Effective prevention strategies are crucial for improving neonatal outcomes.
Purpose of the Study:
- To outline screening and management guidelines for GBS in pregnant patients.
- To reduce the incidence of early-onset neonatal sepsis caused by GBS.
Main Methods:
- Screening pregnant patients for GBS colonization between 36 0/7 and 37 6/7 weeks' gestation.
- Administering intrapartum antibiotic prophylaxis (IAP) for positive cultures, GBS bacteriuria, or history of GBS disease in a newborn.
- Providing IAP based on intrapartum risk factors when GBS status is unknown.
Main Results:
- Timely screening identifies GBS carriers eligible for IAP.
- IAP administration in indicated cases significantly lowers the risk of neonatal GBS sepsis.
- Adherence to guidelines ensures appropriate antibiotic use during labor.
Conclusions:
- Universal GBS screening and targeted IAP are effective in preventing early-onset neonatal sepsis.
- Intrapartum management protocols should be followed to minimize GBS transmission.
- Penicillin is the preferred agent for IAP, with alternatives available for allergic patients.
Abstract:
To decrease risk of early-onset neonatal sepsis from group B streptococcus (GBS), pregnant patients should undergo screening between 36 0/7 and 37 6/7 weeks' gestation. Patients with a positive vaginal-rectal culture, GBS bacteriuria , or history of newborn with GBS disease should receive intrapartum antibiotic prophylaxis (IAP) with an agent targeting GBS. If GBS status is unknown at time of labor, IAP should be administered in cases of preterm birth, rupture of membranes for >18 hours, or intrapartum fever. The antibiotic of choice is intravenous penicillin; alternatives should be considered in cases of penicillin allergy depending on allergy severity.
Related Concept Videos
Rh Blood Group
Sexually Transmitted Infections
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Mitral Valve Prolapse III: Nursing Management
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

